Identifying the Determinants of Bleeding and Hypermobility in Patients With Heavy Menstrual Bleeding
Condition(s):Hypermobile Ehlers-Danlos Syndrome; Heavy Menstrual Bleeding; Hypermobility Syndrome (Disorder)Last Updated:May 24, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Hypermobile Ehlers-Danlos Syndrome; Heavy Menstrual Bleeding; Hypermobility Syndrome (Disorder)Last Updated:May 24, 2023Recruiting
Condition(s):Liver CirrhosisLast Updated:May 12, 2023Not yet recruiting
Condition(s):Neonatal Respiratory DistressLast Updated:July 1, 2021Recruiting
Condition(s):Anticoagulants; Compliance, MedicationLast Updated:June 11, 2020Unknown status
Condition(s):Calculous Cholecystitis; Antibiotic Resistant Infection; Gallbladder InflammationLast Updated:February 3, 2023Not yet recruiting
Condition(s):Type2 Diabetes; Bisphenol ALast Updated:July 27, 2022Recruiting
Condition(s):Glaucoma, Primary Open AngleLast Updated:January 6, 2023Not yet recruiting
Condition(s):Alveolar Bone Loss, Chronic Periodontitis, Lovestatin Gel, RegenerationLast Updated:July 5, 2019Completed
Condition(s):Covid19; Human MilkLast Updated:December 16, 2021Not yet recruiting
Condition(s):Neurodegenerative DiseasesLast Updated:April 27, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.